Summary
Updated Aug 30, 2026
Kevin McCulloch is President and Chief Operating Officer of Xeris Biopharma Holdings, Inc. (XERS). 8 SEC Form 4 filings on record going back to 2025, most recently on 21 August 2026. Most recent open-market trade: sold $120K of XERS on 4 August 2026. Lifetime open-market sales: $843K.
Recent Transactions
12Every recent SEC Form 4 transaction Kevin McCulloch has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Kevin McCulloch go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. 2 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin McCulloch files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Beth Hecht - $1.04M of XERS open-market activity in the last 12 months
- Steven Pieper - $426K of XERS open-market activity in the last 12 months
- Marla Persky - $211K of XERS open-market activity in the last 12 months
- John Patrick Shannon Jr. - $173K of XERS open-market activity in the last 12 months
- Dawn Halkuff - $122K of XERS open-market activity in the last 12 months
- Barbara-Jean Anne Bormann-Kennedy - $98K of XERS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kevin McCulloch?
Kevin McCulloch is a corporate insider, tracked as President and Chief Operating Officer of Xeris Biopharma Holdings, Inc. (XERS). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kevin McCulloch submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kevin McCulloch been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($843K) across all tracked filings.
Where can I see all of Kevin McCulloch's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kevin McCulloch and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial